Kenyon's Institutional Biosafety Committee (IBC), as prescribed by the National Institutes of Health (NIH) is responsible for oversight of experiments involving pathogens and recombinant DNA. The committee will work with researchers to insure 1)pathogen exposure is properly managed and,2) proper containment and destruction of genetically modified organisms.
1.) reviewing all recombinant DNA research projects both a) funded and b) non-funded,
2.) reviewing the use of a) human tissue, b) blood, and c) other infectious agents,
3.) creating policies and procedures for safe laboratory practices,
4.) assisting researchers with compliance and permits,
5.) reporting problems and incidents, and
6.) filing an annual report.
IBC registration and/or approval of research protocols involving these activities is required for compliance with federal regulations governing grants from the National Institute of Health and National Science Foundation.
NIH Office of Biotechnology Activities. Includes guidelines for IBC operations, agency announcements, and additional on-line resources.
IBC Approval Requirements: How to classify your experiments